Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle Diabetic Foot Study.
about
Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical EndocrinologistsThe system of care for the diabetic foot: objectives, outcomes, and opportunitiesDiabetic foot syndrome: Immune-inflammatory features as possible cardiovascular markers in diabetesDiabetic foot ulcer incidence in relation to plantar pressure magnitude and measurement location.Toward Big Data Analytics: Review of Predictive Models in Management of Diabetes and Its ComplicationsNormative data for cutaneous threshold and spatial discrimination in the feet.Understanding the barriers and improving care in type 2 diabetes: Brazilian perspective in time to do more in diabetesAssessing the risk of lower extremity amputations using an administrative data-based foot risk index in elderly patients with diabetes.Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity.Foot care education in patients with diabetes at low risk of complications: a consensus statement.The assessment of clinical distal symmetric polyneuropathy in type 1 diabetes: a comparison of methodologies from the Pittsburgh Epidemiology of Diabetes Complications Cohort.Association between Washing Residue on the Feet and Tinea Pedis in Diabetic Patients.Categories of foot at risk in patients of diabetes at a tertiary care center: Insights into need for foot careLaser therapy for onychomycosis in patients with diabetes at risk for foot complications: study protocol for a randomized, double-blind, controlled trial (LASER-1).British Association of Dermatologists' guidelines for the management of onychomycosis 2014.Safety and efficacy of tinea pedis and onychomycosis treatment in people with diabetes: a systematic reviewRisk factors for foot ulceration in adults with end-stage renal disease on dialysis: study protocol for a prospective observational cohort study.Non-invasive method to analyse the risk of developing diabetic footFoot insensitivity is associated with renal function decline in patients with type 2 diabetes: a cohort study.Plasma adiponectin, IL-6, hsCRP, and TNF-α levels in subject with diabetic foot and their correlation with clinical variables in a North Indian tertiary care hospital.Associated risk factors and management of chronic diabetic foot ulcers exceeding 6 months' durationClinical decision support software for diabetic foot risk stratification: development and formative evaluationEmerging drugs for diabetic foot ulcers.Baseline characteristics and risk factors for ulcer, amputation and severe neuropathy in diabetic foot at risk: the BRAZUPA study.Prediction of protective sensory loss, neuropathy and foot ulceration in type 2 diabetes.Cardiovascular Autonomic Dysfunction Predicts Diabetic Foot Ulcers in Patients With Type 2 Diabetes Without Diabetic PolyneuropathyFoot care education and self management behaviors in diverse veterans with diabetesThe effect of cumulative glycemic burden on the incidence of diabetic foot disease.History of foot ulcer increases mortality among individuals with diabetes: ten-year follow-up of the Nord-Trøndelag Health Study, Norway.Arterial stiffness, endothelial and cognitive function in subjects with type 2 diabetes in accordance with absence or presence of diabetic foot syndrome.Myricetin, a potent natural agent for treatment of diabetic skin damage by modulating TIMP/MMPs balance and oxidative stress.Review paper: basic concepts to novel therapies: a review of the diabetic foot.Risk stratification systems for diabetic foot ulcers: a systematic review.Dermatologic manifestation of diabetes.Diagnostics and treatment of the diabetic foot.Predictive factors for diabetic foot ulceration: a systematic review.Therapeutic potential of TDT 067 (terbinafine in Transfersome): a carrier-based dosage form of terbinafine for onychomycosis.Peripheral arterial disease and revascularization of the diabetic foot.Wound management of chronic diabetic foot ulcers: from the basics to regenerative medicine.Significant J-shaped association between body mass index (BMI) and diabetic foot ulcers.
P2860
Q24650016-482D2BD7-39B2-4855-ABD8-67122035CBEFQ26861462-3438E6E4-B70D-4C7F-BAA4-59431BC294EFQ28082521-66D3CCB9-B9C5-4D6A-85DC-B7B9F2CBAB45Q30597315-6EDFF7C2-D5B5-47E1-A52C-BA5ACC9E252AQ31005299-988BBF5A-BAA8-40AA-B014-CDEDEA5F9884Q31149124-532401FA-B086-48C2-B4E4-0EE28CA4B130Q33805311-1432E7CA-8046-44A6-8C01-07C7D637CB7EQ33919154-F2B61818-915C-4E97-8470-7C371EABB76AQ34158063-003D5761-79D2-45DA-AA44-AB4059DE1751Q34579580-AFC41BF9-AE53-4524-B076-4B80F69C7F5BQ35119200-777A05F8-B14F-4583-9C5B-E1B85F0B8673Q35156125-D9B7D43F-8EF4-42C6-8958-D76AB4AAFECAQ35197992-942668A7-749C-48C9-9D79-FB6451E5E2CDQ35238148-32A90FD2-8AF6-4816-A394-9239E829E687Q35437556-F26F1793-C26A-4915-9215-3B86CDBA7D83Q35640828-D9594AD8-DE0A-45A0-8EEF-F44E4B4BEFCBQ36073895-86EDF497-3094-4D52-A19E-15782DC1634AQ36179990-E9A3E95D-7197-4391-8D6A-1C64BDC9D389Q36201450-44E8E5EB-7A7F-4119-92A4-9239CC098683Q36331637-95AC9157-BD05-4D18-8449-A5FDD98F26E1Q36360604-146F1678-BA8C-40CC-B036-58F274E14D81Q36366098-2A502D69-D692-40F7-937D-4C00991D9457Q36634279-0978E31A-E033-4762-8E3C-8EB1400A5BCBQ36694545-CECCF45B-258B-49F3-9D26-78AADFB8297EQ36919692-375480CF-3843-42F3-B815-D39EEC66B075Q37205357-A3B38755-29FC-4090-A86A-F9BA29917EA0Q37423663-8F6F7F5C-3954-499A-8AD8-586C0A593ACFQ37424026-188A8F54-EFF5-4742-83A8-98884AEE8E1BQ37437085-6C7D7099-CE4F-460B-ADD5-2E839BE2EED4Q37565982-FD095730-462A-46E4-AAD8-6194DDA3C5C2Q37687699-903DA098-59A2-4DDF-8DC8-4B74D8681B89Q37756329-54C54A05-9259-4ECC-AD85-6E2AF2EDC5C1Q37830376-5BEAA5F4-F7C6-44F8-9B87-6DBCA997A2FBQ37919146-6006248A-909E-4ED8-8D55-9263AB9EEE03Q37988404-A7C32458-C44C-43CF-B734-A6C6D9703427Q38021436-365CCEBA-3992-45F3-9D09-33E5B460C764Q38033192-11F8CA96-DCA7-46AF-AE80-B03256508A2CQ38282150-5F4FCD55-5D82-4E19-BD25-A0EBF6BA8DD8Q38329624-CE8EFD58-6D4D-4E24-94F9-14A73C8B613AQ38440143-8BF17176-21AB-4C30-9763-4A589E776DEC
P2860
Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle Diabetic Foot Study.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Prediction of diabetic foot ul ...... e Seattle Diabetic Foot Study.
@ast
Prediction of diabetic foot ul ...... e Seattle Diabetic Foot Study.
@en
type
label
Prediction of diabetic foot ul ...... e Seattle Diabetic Foot Study.
@ast
Prediction of diabetic foot ul ...... e Seattle Diabetic Foot Study.
@en
prefLabel
Prediction of diabetic foot ul ...... e Seattle Diabetic Foot Study.
@ast
Prediction of diabetic foot ul ...... e Seattle Diabetic Foot Study.
@en
P2093
P356
P1433
P1476
Prediction of diabetic foot ul ...... e Seattle Diabetic Foot Study.
@en
P2093
Jessie H Ahroni
Karin M Nelson
Patrick J Heagerty
Victoria Cohen
P304
P356
10.2337/DC05-2031
P407
P577
2006-06-01T00:00:00Z